Position in CGC
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$1,501,613
-$6,964,850 QoQ
Shares Held
1,582,312
-78.7% QoQ
Ownership
0.375%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
10 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in CGC Over Time
Shares Held
Position Value (USD)
Derivatives in CGC
reported options exposure · as of Mar 31, 2026CallValue
$81,234
CallShares
85,600
PutValue
$322,184
PutShares
339,500
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026JANE STREET GROUP, LLC holds $182,242,360 across 41 Drug Manufacturers - Specialty & Generic names. CGC ranks #20 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,464,638 | $44,114,896 | |
| 2 | LQDA |
Liquidia Corp
|
795,884 | $30,036,661 | |
| 3 | VTRS |
Viatris Inc
|
2,192,665 | $29,622,903 | |
| 4 | HLN |
Haleon plc
|
2,291,768 | $22,940,596 | |
| 5 | BCRX |
Biocryst Pharmaceuticals Inc
|
622,607 | $5,927,217 | |
| 6 | HIMS |
Hims & Hers Health, Inc.
|
240,170 | $4,985,929 | |
| 7 | AQST |
Aquestive Therapeutics, Inc.
|
1,030,050 | $4,274,707 | |
| 8 | XERS |
Xeris Biopharma Holdings, Inc.
|
725,616 | $4,208,572 |
All Filings in CGC
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $322,184 | 339,500 | Put | Defined | 2026-05-12 | |
| 2026-03-31 | $81,234 | 85,600 | Call | Defined | 2026-05-12 | |
| 2026-03-31 | $1,501,613 | 1,582,312 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $8,466,463 | 7,426,723 | Shares | Defined | 2026-02-12 | |
| 2025-12-31 | $316,122 | 277,300 | Put | Defined | 2026-02-12 | |
| 2025-12-31 | $866,856 | 760,400 | Call | Defined | 2026-02-12 | |
| 2025-09-30 | $3,197,603 | 2,190,140 | Shares | Defined | 2025-11-14 | |
| 2025-09-30 | $136,831 | 93,720 | Call | Defined | 2025-11-14 | |
| 2025-09-30 | $319,740 | 219,000 | Put | Defined | 2025-11-14 | |
| 2025-06-30 | $127,978 | 104,900 | Call | Defined | 2025-08-14 | |
| 2025-06-30 | $588,510 | 482,386 | Shares | Defined | 2025-08-14 | |
| 2025-06-30 | $45,872 | 37,600 | Put | Defined | 2025-08-14 | |
| 2025-03-31 | $774,020 | 850,573 | Shares | Defined | 2025-05-19 | |
| 2025-03-31 | $97,006 | 106,600 | Call | Defined | 2025-05-19 | |
| 2024-12-31 | $1,282,850 | 468,194 | Shares | Defined | 2025-02-14 | |
| 2024-12-31 | $57,375 | 20,940 | Put | Defined | 2025-02-14 | |
| 2024-12-31 | $1,336,435 | 487,750 | Call | Defined | 2025-02-14 | |
| 2024-09-30 | $4,839,039 | 1,003,950 | Call | Defined | 2024-11-15 | |
| 2024-09-30 | $1,281,787 | 265,931 | Shares | Defined | 2024-11-15 | |
| 2024-09-30 | $323,855 | 67,190 | Put | Defined | 2024-11-15 | |
| 2024-06-30 | $1,154,685 | 179,021 | Shares | Defined | 2024-08-15 | |
| 2024-03-31 | $11,407,400 | 1,321,831 | Shares | Defined | 2024-05-16 | |
| 2023-12-31 | $1,569,433 | 307,130 | Shares | Defined | 2024-02-15 | |
| No filing history on record for this holder in this stock. | ||||||